Safety and immunogenicity of COVID‐19 vaccination in patients with hepatocellular carcinoma (CHESS‐NMCID 2101): A multicenter prospective study

Xiaolong Qi(Zhongda Hospital Southeast University), Wenhong Zhang(Fudan University), Luxiang Liu(Peking University), Jiansheng Huang(Vanderbilt University Medical Center), Jingwen Ai(Fudan University), Li Bian(Regeneron (United States)), Qiran Zhang(Fudan University), Hailei Ji(Jiangsu University), Wei Qin(Baoding People's Hospital), Jiansong Ji(Lishui University), Shubo Chen(Hebei Medical University), Zhaolan Yan(The Fourth People's Hospital), Aifang Hou, Qing‐Lei Zeng, Huiling Xiang(Tianjin Third Central Hospital), Zhiyun Hou(Zoucheng People's Hospital), Nina Zhang(Nanjing Drum Tower Hospital), Hongmei Zu(The Fourth People's Hospital), Dengxiang Liu(Hebei Medical University), Xuying Zhang(Hebei Medical University), Chuan Liu(Wuhan University), Yun Wang(The Fourth People's Hospital), Xiaodong Wang(Baoding People's Hospital), Zhen Zhang(Chinese Academy of Agricultural Sciences), Jing Liang(Jiaxing Vocational Technical College), Guohong Ge(Jiangsu University), Jitao Wang(Hebei Medical University), Dan Xu, Qianqian Li(Tianjin Third Central Hospital), Aiguo Zhang(Henan University), Yifei Huang(First Hospital of Lanzhou University), Shengqiang Zou(Jiangsu University), Zhongwei Zhao(Central South University), Jie Yang(Xijing Hospital), Jinlong Li(Hebei Medical University), Ye Gu(The Sixth People's Hospital of Shenyang), Jiaojian Lv(Lishui City People's Hospital), Xiufang Du, Yanna Liu(Linyi University)
Journal of Medical Virology
July 11, 2022
Cited by 12


Related Papers